Amino acid determinants of alpha 7 nicotinic acetylcholine receptor surface expression

K T Dineley1, J W Patrick

  • 1Division of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA. kdineley@sensor.neusc.bcm.tmc.edu

Insights

Researchers identified specific amino acids controlling alpha7 nicotinic acetylcholine receptor (nAChR) surface expression. This finding allows manipulation of surface receptor levels without altering total receptor numbers, impacting synaptic function.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Transient transfection typically fails to yield detectable surface expression of alpha7 nicotinic acetylcholine receptors (nAChRs).
  • Unlike other ligand-gated ion channels, such as the 5-hydroxytryptamine type 3 (5-HT3) receptor, nAChRs present challenges for surface expression studies.
  • Stable cell lines show variable nAChR surface expression, suggesting cell-specific factors influence receptor localization.

Purpose of the Study:

  • To investigate the intrinsic determinants of alpha7 nAChR surface expression.
  • To identify specific amino acid residues controlling the distribution of alpha7 nAChRs between the cell surface and intracellular compartments.
  • To explore methods for manipulating alpha7 nAChR surface expression levels.

Main Methods:

  • Construction and expression of alpha7-5-HT3 chimeric receptor subunit cDNAs in a transient transfection system.
  • Quantification of surface receptor expression for various chimeric constructs.
  • Analysis of amino acid sequences to pinpoint determinants of receptor localization.

Main Results:

  • Specific amino acids within the alpha7 nAChR were identified as critical for controlling receptor trafficking to the cell surface.
  • Surface expression levels could be modulated by altering these identified amino acid residues, independent of total receptor quantity.
  • These determinants were found to be functional across different cell lines and transfection methods.

Conclusions:

  • Intrinsic properties of the alpha7 nAChR protein, specifically certain amino acid sequences, dictate its surface expression levels.
  • Targeting these determinants offers a novel strategy to manipulate alpha7 nAChR surface expression, potentially influencing synaptic efficacy.
  • This research provides a foundation for understanding and engineering nAChR surface presentation.

Related Concept Videos

Amino acids03:42

Amino acids

Amino acids are the monomers that comprise proteins. Each amino acid has the same fundamental structure, which consists of a central carbon atom, or the alpha (α) carbon, bonded to an amino group (NH2), a carboxyl group (COOH), and to a hydrogen atom. Every amino acid also has another atom or group of atoms bonded to the central atom known as the R group. There are 20 common amino acids present in proteins, each with a different R group. Variation in the amino acid sequence is responsible for...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...